Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Neurosurg Focus ; 46(Suppl_2): V1, 2019 Apr 01.
Article in English | MEDLINE | ID: mdl-30939434

ABSTRACT

Dural arteriovenous fistulae (dAVFs) are vascular anomalies formed by abnormal connections between branches of dural arteries and dural veins or dural venous sinus(es). These pathologic shunts constitute 10%-15% of all intracranial arteriovenous malformations. The hallmark of malignant dAVFs is the presence of cortical venous drainage, a finding that increases the likelihood of nonhemorrhagic neurologic deficit, intracranial hemorrhage, and mortality if left unaddressed. Endovascular approaches have become the primary modality for the treatment of dAVFs. The authors present a case of staged endovascular transarterial embolization of a malignant dAVF running parallel to the left transverse sinus in a patient with headaches and pulsatile tinnitus. The fistula was completely treated using Onyx and n-butyl cyanoacrylate.The video can be found here: https://youtu.be/GSAto_wlC3I.


Subject(s)
Central Nervous System Vascular Malformations/therapy , Dimethyl Sulfoxide/pharmacology , Embolization, Therapeutic , Intracranial Arteriovenous Malformations/therapy , Aged , Central Nervous System Vascular Malformations/pathology , Cerebral Angiography/methods , Cyanoacrylates/pharmacology , Enbucrilate/pharmacology , Endovascular Procedures , Female , Humans , Intracranial Arteriovenous Malformations/diagnosis , Male , Middle Aged
3.
Interv Neurol ; 4(3-4): 113-9, 2016 Mar.
Article in English | MEDLINE | ID: mdl-27051407

ABSTRACT

BACKGROUND: Posterior circulation strokes comprise approximately 20-25% of all strokes of ischemic origin. Strokes affecting this area carry a significantly higher risk for subsequent stroke or death as compared to anterior circulation strokes. Embolic protection device (EPD) use for carotid artery stenosis has translated into percutaneous interventions of proximal vertebral artery (VA) stenosis. However, the use of EPDs when treating intracranial lesions has yet to be studied and may not be feasible as the vessel caliber is frequently smaller than in existing devices. OBJECTIVE: The aim of this study is to describe a proximal aspiration technique used during the treatment of intracranial VA and basilar artery (BA) atherosclerotic disease. METHODS: Proximal embolic protection was utilized during the treatment of intracranial VA/BA stenosis with angioplasty and stenting in patients with medically refractory disease. RESULTS: Three patients with severe symptomatic posterior circulation stenosis refractory to medical management were treated with angioplasty and stenting utilizing proximal aspiration. Pre- and post-treatment angiograms and MRIs were compared. Treated vascular stenoses were significantly improved, without new neurological deficits or ischemic injury identified on imaging. CONCLUSIONS: The proposed technique of proximal embolic protection may help overcome the challenge of embolus propagation inherent to the treatment modality that was encountered during the treatment of intracranial VA/BA stenosis.

5.
Mol Cell Biol ; 30(10): 2341-52, 2010 May.
Article in English | MEDLINE | ID: mdl-20231360

ABSTRACT

Combined deficiencies of poly(ADP)ribosyl polymerase 1 (PARP1) and ataxia telangiectasia mutated (ATM) result in synthetic lethality and, in the mouse, early embryonic death. Here, we investigated the genetic requirements for this lethality via analysis of mice deficient for PARP1 and either of two ATM-regulated DNA damage response (DDR) factors: histone H2AX and 53BP1. We found that, like ATM, H2AX is essential for viability in a PARP1-deficient background. In contrast, deficiency for 53BP1 modestly exacerbates phenotypes of growth retardation, genomic instability, and organismal radiosensitivity observed in PARP1-deficient mice. To gain mechanistic insights into these different phenotypes, we examined roles for 53BP1 in the repair of replication-associated double-strand breaks (DSBs) in several cellular contexts. We show that 53BP1 is required for DNA-PKcs-dependent repair of hydroxyurea (HU)-induced DSBs but dispensable for RPA/RAD51-dependent DSB repair in the same setting. Moreover, repair of mitomycin C (MMC)-induced DSBs and sister chromatid exchanges (SCEs), two RAD51-dependent processes, are 53BP1 independent. Overall, our findings define 53BP1 as a main facilitator of nonhomologous end joining (NHEJ) during the S phase of the cell cycle, beyond highly specialized lymphocyte rearrangements. These findings have important implications for our understanding of the mechanisms whereby ATM-regulated DDR prevents human aging and cancer.


Subject(s)
Genome , Histones/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Poly(ADP-ribose) Polymerases/metabolism , Aging/physiology , Animals , B-Lymphocytes/cytology , B-Lymphocytes/metabolism , Chromosomal Proteins, Non-Histone , DNA/drug effects , DNA/genetics , DNA/metabolism , DNA/radiation effects , DNA Breaks, Double-Stranded/drug effects , DNA Breaks, Double-Stranded/radiation effects , DNA Repair , DNA-Activated Protein Kinase/genetics , DNA-Activated Protein Kinase/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Female , Genomic Instability , Histones/genetics , Humans , Hydroxyurea/pharmacology , In Situ Hybridization, Fluorescence , Intracellular Signaling Peptides and Proteins/genetics , Male , Mice , Mice, Knockout , Mitomycin/pharmacology , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Nucleic Acid Synthesis Inhibitors/pharmacology , Phenotype , Poly (ADP-Ribose) Polymerase-1 , Poly(ADP-ribose) Polymerases/genetics , Rad51 Recombinase/genetics , Rad51 Recombinase/metabolism , Radiation, Ionizing , Sister Chromatid Exchange , Tumor Suppressor p53-Binding Protein 1
SELECTION OF CITATIONS
SEARCH DETAIL
...